|
|
Post by babaoriley on May 26, 2014 11:14:25 GMT -5
Will attempt to go for MNKD instead!! Reports are that Pfizer can take down MNKD for "a bit less" than what they were prepared to spend for AZ! Mann insists that he won't support deal unless Pfizer changes its name to "Apfrezzer." Pfizer's CEO was open to the idea, responding, "sure, we will change our name to Apfrezzer and get into the large home appliance business, too." Those reports are not widely disseminated yet, perhaps confined to this board for now.
LOL, can you imagine them "inhaling" MNKD after choking on Exubera? I think it would be a smart move!
|
|
|
|
Post by 4Balance on May 26, 2014 12:33:15 GMT -5
Would they be imbibing "the hair of the dog", or haunted by the ghost of a failed past? Me thinks, the latter. WAY too much baggage.
|
|
|
|
Post by seanismorris on May 26, 2014 12:39:33 GMT -5
I'm not sure Pfizer is a competent partner to market Afrezza, I'd rather have Novo Nordisk or someone else established in the diabetes space (someone with a strong relationship with the doctors already). Pfizer did partnership with Merck (on diabetes) a while back so Pfizer would definitely be interested... But did they partner (with Merck) because Pfizer doesn't have the inhouse experience? Pfizer does have a lot of cash, but most of it is overseas, making them an unlikely buyer of Mannkind (in its entirety). www.reuters.com/article/2013/04/29/us-merck-deal-pfizer-idUSBRE93S0CN20130429After Afrezza is approved there is a possibility for Mannkind and Pfizer to partner on other drug formulations using Technosphere. Pfizer is badly in need of expanding their pipeline. Pain meds would be a great oportunity for both parties. www.pfizer.com/partnering/areas_of_interest/pain_and_sensory_disorders |
|
|
|
Post by notamnkdmillionaire on May 26, 2014 17:43:24 GMT -5
I really don't think we will see PFizzure as a partner. Could be wrong but you won't.
|
|
